Page last updated: 2024-10-29

ketanserin and Helicobacter Infections

ketanserin has been researched along with Helicobacter Infections in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engelmann, BE1
Bindslev, N1
Poulsen, SS1
Larsen, R1
Hansen, MB1

Other Studies

1 other study available for ketanserin and Helicobacter Infections

ArticleYear
Functional characterization of serotonin receptor subtypes in human duodenal secretion.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 98, Issue:2

    Topics: Adult; Aged; Bumetanide; Dioxanes; Duodenum; Female; Helicobacter Infections; Helicobacter pylori; H

2006